- Home
- RYI vs CRMD Comparison
RYI vs CRMD Comparison
Compare RYI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYI
- CRMD
- Stock Information
- Founded
- RYI 1842
- CRMD 2006
- Country
- RYI United States
- CRMD United States
- Employees
- RYI N/A
- CRMD N/A
- Industry
- RYI Metal Fabrications
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- RYI Industrials
- CRMD Health Care
- Exchange
- RYI Nasdaq
- CRMD Nasdaq
- Market Cap
- RYI 699.3M
- CRMD 973.3M
- IPO Year
- RYI N/A
- CRMD 2010
- Fundamental
- Price
- RYI $23.32
- CRMD $11.40
- Analyst Decision
- RYI Hold
- CRMD Strong Buy
- Analyst Count
- RYI 1
- CRMD 7
- Target Price
- RYI $25.00
- CRMD $17.33
- AVG Volume (30 Days)
- RYI 243.6K
- CRMD 2.5M
- Earning Date
- RYI 07-29-2025
- CRMD 08-13-2025
- Dividend Yield
- RYI 3.19%
- CRMD N/A
- EPS Growth
- RYI N/A
- CRMD N/A
- EPS
- RYI N/A
- CRMD 0.28
- Revenue
- RYI $4,495,200,000.00
- CRMD $82,553,827.00
- Revenue This Year
- RYI $0.35
- CRMD $238.38
- Revenue Next Year
- RYI $3.40
- CRMD $53.52
- P/E Ratio
- RYI N/A
- CRMD $41.86
- Revenue Growth
- RYI N/A
- CRMD N/A
- 52 Week Low
- RYI $17.18
- CRMD $3.61
- 52 Week High
- RYI $27.41
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- RYI 60.50
- CRMD 39.52
- Support Level
- RYI $21.22
- CRMD $12.14
- Resistance Level
- RYI $23.25
- CRMD $17.43
- Average True Range (ATR)
- RYI 0.88
- CRMD 0.69
- MACD
- RYI 0.32
- CRMD -0.51
- Stochastic Oscillator
- RYI 94.09
- CRMD 4.60
About RYI Ryerson Holding Corporation
Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.